A Phase 3 clinical trial testing soticlestat in people with Dravet syndrome showed that patients given soticlestat tended…
Articles by Marisa Wexler, MS
Avata Biosciences is gearing up for a Phase 3 clinical trial to test SAP-021, the company’s oral capsule formulation of…
Among recent treatments to reduce the risk of seizures in people with Dravet syndrome, Fintepla (fenfluramine) appears to…
Treatment with Fintepla (fenfluramine) appeared to be reasonably safe and to effectively lower seizure frequency in five…
Available treatments aren’t enough to fully control seizures for most people with Dravet syndrome, and most have side effects…
Epidiolex (cannabidiol), an approved treatment for seizures in Dravet syndrome, may in some rare cases cause side effects…
Treatment with a noninvasive procedure called transcranial static magnetic stimulation (tSMS) led to significantly less seizure activity in a…
Diacomit (stiripentol), known to help control seizures in people with Dravet syndrome, also may aid those with other childhood…
The frequency of seizures decreased substantially for most children with medication-resistant epileptic disorders such as Dravet syndrome at a…
Epidiolex (cannabidiol) reduces the frequency of seizures for most people with Dravet syndrome and also leads to gains…